Stockscreener 앱 받기
5.53
6.43%
-0.38
시간 외 거래:
5.50
-0.03
-0.54%
전일 마감가:
$5.91
열려 있는:
$5.91
하루 거래량:
7.18M
Relative Volume:
1.27
시가총액:
$1.65B
수익:
$38.03M
순이익/손실:
$-146.40M
주가수익비율:
-10.63
EPS:
-0.52
순현금흐름:
$-121.38M
1주 성능:
-6.27%
1개월 성능:
+29.21%
6개월 성능:
+167.15%
1년 성능:
+121.20%
1일 변동 폭
$5.46
$5.9366
1주일 범위
$5.46
$6.515
52주 변동 폭
$1.8906
$6.515
앱셀레라바이오로직스 Stock (ABCL) Company Profile
명칭
Abcellera Biologics Inc
전화
(604) 559-9005
주소
150 W 4TH AVENUE, VANCOUVER
ABCL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABCL
Abcellera Biologics Inc
|
5.53 | 1.77B | 38.03M | -146.40M | -121.38M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
앱셀레라바이오로직스 Stock (ABCL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 재개 | Leerink Partners | Outperform |
| 2024-08-20 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2024-02-22 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-11-06 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-10-13 | 재개 | Piper Sandler | Overweight |
| 2023-02-28 | 개시 | Cowen | Outperform |
| 2022-12-15 | 개시 | Goldman | Buy |
| 2022-11-16 | 개시 | Truist | Buy |
| 2021-12-21 | 개시 | The Benchmark Company | Buy |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-01-05 | 개시 | BMO Capital Markets | Outperform |
| 2021-01-05 | 개시 | Berenberg | Buy |
| 2021-01-05 | 개시 | Credit Suisse | Outperform |
| 2021-01-05 | 개시 | SVB Leerink | Outperform |
| 2021-01-05 | 개시 | Stifel | Buy |
모두보기
앱셀레라바이오로직스 주식(ABCL)의 최신 뉴스
Is now a turning point for AbCellera Biologics Inc.Earnings Recap Report & Fast Gain Stock Trading Tips - newser.com
Why AbCellera Biologics Inc. (8QQ) stock could rally stronglyNew Guidance & Free Technical Pattern Based Buy Signals - newser.com
Analyzing AbCellera Biologics Inc. with risk reward ratio chartsJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com
Custom watchlist performance reports with AbCellera Biologics Inc.2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
AbCellera Biologics Hits New 52-Week High of $6.51 - Markets Mojo
Real time alert setup for AbCellera Biologics Inc. performanceStop Loss & Weekly High Potential Stock Alerts - newser.com
Does AbCellera Biologics Inc. qualify in momentum factor screening2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Is AbCellera Biologics Inc. (8QQ) stock cheap vs fundamentalsWeekly Trend Report & Safe Swing Trade Setups - newser.com
Is AbCellera Biologics Inc. (8QQ) stock a top dividend aristocrat candidateEarnings Beat & Expert Curated Trade Setups - newser.com
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025 - PharmiWeb.com
AbCellera Biologics: Entering Growth Phase After A Pause (NASDAQ:ABCL) - Seeking Alpha
AbCellera Biologics Inc. recovery potential after sell off2025 Analyst Calls & Technical Confirmation Trade Alerts - newser.com
Is AbCellera Biologics Inc. stock a dividend growth opportunity2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Forecasting AbCellera Biologics Inc. price range with options dataJuly 2025 Short Interest & Technical Entry and Exit Tips - newser.com
Should you hold or exit AbCellera Biologics Inc. nowWeekly Stock Summary & Daily Stock Trend Reports - newser.com
Statistical indicators supporting AbCellera Biologics Inc.’s strengthQuarterly Market Review & Fast Gaining Stock Reports - newser.com
How AbCellera Biologics Inc. (8QQ) stock behaves in tightening cyclesEarnings Miss & Real-Time Volume Triggers - newser.com
Leading vs lagging indicators on AbCellera Biologics Inc. performanceTrade Exit Summary & Short-Term High Return Ideas - newser.com
Is AbCellera Biologics Inc. stock safe for conservative investors2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
How AbCellera Biologics Inc. stock benefits from tech adoption2025 Geopolitical Influence & Daily Stock Trend Watchlist - newser.com
Published on: 2025-10-05 03:44:08 - newser.com
AbCellera Biologics Hits Day High with 8.17% Surge in Stock Price - Markets Mojo
AbCellera (ABCL) Is Up 24.5% After Strong Q2 Revenue Beat and Advancing Clinical Pipeline - Yahoo
How high can AbCellera Biologics Inc. stock goRate Cut & Technical Pattern Recognition Alerts - newser.com
Using RSI to spot recovery in AbCellera Biologics Inc.Trade Volume Summary & Advanced Technical Analysis Signals - newser.com
Published on: 2025-10-03 03:02:14 - newser.com
Is AbCellera Biologics Inc. (8QQ) stock in buy zone after pullback2025 Historical Comparison & AI Driven Stock Movement Reports - newser.com
Published on: 2025-10-03 00:01:15 - newser.com
앱셀레라바이오로직스 (ABCL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.74%
자본화:
|
볼륨(24시간):